Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes (Q24235466)

2

0 references

Naveen Rao

3

0 references

Yenal Dundar

4

0 references

Rumona C Dickson

5

0 references

Adrian Bagust

Cochrane Database of Systematic Reviews

6

0 references

publication date

12 May 2010

0 references

published in

0 references

cites work

Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries: a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT).

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

A paclitaxel-eluting stent for the prevention of coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: the DECODE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Sirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

ABT-578-eluting stents. The promising successor of sirolimus- and paclitaxel-eluting stent concepts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Randomized, double-blind, multicenter study of the polymer-based 17-beta estradiol-eluting stent for treatment of native coronary artery lesions: six-month results of the ETHOS I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Clinical experiences using everolimus-eluting stents in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: serial angiographic and sonographic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Three-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Prima

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

One-year results of the SCORPIUS study: a German multicenter investigation on the effectiveness of sirolimus-eluting stents in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

High-dose bolus tirofiban and sirolimus eluting stent versus abiciximab and bare metal stent in acute myocardial infarction (STRATEGY) study--protocol design and demography of the first 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Sirolimus-eluting versus uncoated stents in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Cost-effectiveness of drug-eluting stents in a US Medicare setting:a cost-utility analysis with 3-year clinical follow-up data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Percutaneous coronary interventions in Europe: prevalence, numerical estimates, and projections based on data up to 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Clinical end points in coronary stent trials: a case for standardized definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Percutaneous transluminal rotational atherectomy for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Coronary artery stents: a rapid systematic review and economic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

7 January 2021

Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

7 January 2021

New developments in percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

7 January 2021

Longer, better studies of coronary stents are needed, FDA tells industry

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

7 January 2021

7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

7 January 2021

Cost-effectiveness of coronary stenting in acute myocardial infarction: results from the stent primary angioplasty in myocardial infarction (stent-PAMI) trial

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

7 January 2021

Drug-eluting stents: a systematic review and economic evaluation.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

7 January 2021

Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study.

1 reference

https://api.crossref.org/works/10.1002/14651858.CD004587.PUB2

7 January 2021

High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD004587.PUB2

Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial

9 February 2024

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1002/14651858.CD004587.PUB2

10.1002/14651858.CD004587.PUB2

9 February 2024

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

20464732

1 reference

Consolidated OpenCitations Corpus – April 2017